tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

IQVIQVIA

Health care · Research Services · NYSE
Compare with peers → Embed
What it said it expected, against what it reported

2 targets with a reported result

Releases of the last 3 years
Above the range
2
above the last range given
Within the range
0
of 2 range targets
Below the range
0
below the last range given

The numbers IQV said it expected, in its earnings releases, next to what it then reported for the same period.

Target by target

Each target, with the sentence it came from

Release and 10-Q or 10-K
TargetWhat the company saidReportedResult
EBITDA (company-defined)
Fiscal 2026
Given $3.98B to $4.03B release 2026-02-05
Kept $3.98B to $4.03B release 2026-05-05
Raised $4.00B to $4.05B release 2026-07-28
Raised $4.03B to $4.05B release 2026-10-27
– No standard number
The company's words
Issues Full-Year 2026 Guidance … Full-year 2026 Revenue guidance of $17,150 million to $17,350 million, Adjusted EBITDA of $3,975 million to $4,025 million and Adjusted Diluted Earnings per Share of $12.55 to $12.85 release 2026-02-05
Full-Year 2026 Guidance … The company is reaffirming its full-year 2026 guidance for revenue to be between $17,150 million and $17,350 million, and for Adjusted EBITDA to be between $3,975 million and $4,025 million. release 2026-05-05
Full-Year 2026 Guidance … To reflect stronger organic revenue growth, and changes in the M&A and foreign exchange impacts, the company is raising its full-year 2026 guidance for revenue to be between $17,275 million and $17,475 million, for Adjusted EBITDA to be between $4,000 million and $4,050 million and for Adjusted Diluted Earnings per Share to be between $12.80 and $13.00. release 2026-07-28
Full-Year 2026 Guidance … The company is raising its full-year 2026 guidance for revenue to be between $17,350 million and $17,500 million, for Adjusted EBITDA to be between $4,025 million and $4,055 million and for Adjusted Diluted Earnings per Share to be between $12.90 and $13.00. release 2026-10-27
Diluted EPS (company-defined)
Fiscal 2026
Given $12.55 to $12.85 release 2026-02-05
Raised $12.65 to $12.95 release 2026-05-05
– No standard number
The company's words
Issues Full-Year 2026 Guidance … Full-year 2026 Revenue guidance of $17,150 million to $17,350 million, Adjusted EBITDA of $3,975 million to $4,025 million and Adjusted Diluted Earnings per Share of $12.55 to $12.85 release 2026-02-05
Reaffirming full-year 2026 guidance for revenue and Adjusted EBITDA; raising full-year 2026 guidance for Adjusted Diluted Earnings per Share to $12.65 - $12.95 release 2026-05-05
Revenue
Fiscal 2026
Given $17.15B to $17.35B release 2026-02-05
Kept $17.15B to $17.35B release 2026-05-05
Raised $17.27B to $17.48B release 2026-07-28
Raised $17.35B to $17.50B release 2026-10-27
– Not reported yet
The company's words
Full-year 2026 Revenue guidance of $17,150 million to $17,350 million, Adjusted EBITDA of $3,975 million to $4,025 million and Adjusted Diluted Earnings per Share of $12.55 to $12.85 release 2026-02-05
The company is reaffirming its full-year 2026 guidance for revenue to be between $17,150 million and $17,350 million, and for Adjusted EBITDA to be between $3,975 million and $4,025 million. release 2026-05-05
Full-Year 2026 Guidance … To reflect stronger organic revenue growth, and changes in the M&A and foreign exchange impacts, the company is raising its full-year 2026 guidance for revenue to be between $17,275 million and $17,475 million, for Adjusted EBITDA to be between $4,000 million and $4,050 million and for Adjusted Diluted Earnings per Share to be between $12.80 and $13.00. release 2026-07-28
The company is raising its full-year 2026 guidance for revenue to be between $17,350 million and $17,500 million, for Adjusted EBITDA to be between $4,025 million and $4,055 million and for Adjusted Diluted Earnings per Share to be between $12.90 and $13.00. release 2026-10-27
Revenue (company-defined)
Fiscal 2026
Given $17.27B to $17.48B release 2026-07-28
– No standard number
The company's words
To reflect stronger organic revenue growth, and changes in the M&A and foreign exchange impacts, the company is raising its full-year 2026 guidance for revenue to be between $17,275 million and $17,475 million, for Adjusted EBITDA to be between $4,000 million and $4,050 million and for Adjusted Diluted Earnings per Share to be between $12.80 and $13.00. release 2026-07-28
EBITDA (company-defined)
Fiscal 2025 (ended 2025-12-31)
Given $3.77B to $3.88B release 2025-02-06
Kept $3.77B to $3.88B release 2025-05-06
Lowered $3.75B to $3.83B release 2025-07-22
Narrowed $3.77B to $3.80B release 2025-10-28
– No standard number
The company's words
Reaffirms Full-Year 2025 Guidance … Full-year 2025 Revenue guidance of $15,725 million to $16,125 million, Adjusted EBITDA of $3,765 million to $3,885 million and Adjusted Diluted Earnings per Share of $11.70 to $12.10 release 2025-02-06
Full-Year 2025 Guidance … The company reaffirms its profit guidance of Adjusted EBITDA between $3,765 million and $3,885 million, and Adjusted Diluted Earnings per Share between $11.70 and $12.10. release 2025-05-06
Full-Year 2025 Guidance … The company is updating its full-year 2025 guidance as follows: revenue between $16,100 million and $16,300 million, Adjusted EBITDA between $3,750 million and $3,825 million, and Adjusted Diluted Earnings per Share between $11.75 and $12.05. release 2025-07-22
Full-Year 2025 Guidance … The company is reaffirming the midpoint of its full-year 2025 guidance and narrowing the ranges as follows: revenue expected to be between $16,150 million and $16,250 million, Adjusted EBITDA expected to be between $3,775 million and $3,800 million, and Adjusted Diluted Earnings per Share expected to be between $11.85 and $11.95. release 2025-10-28
Diluted EPS (company-defined)
Fiscal 2025 (ended 2025-12-31)
Given $11.70 to $12.10 release 2025-02-06
Kept $11.70 to $12.10 release 2025-05-06
Narrowed $11.75 to $12.05 release 2025-07-22
Narrowed $11.85 to $11.95 release 2025-10-28
– No standard number
The company's words
Reaffirms Full-Year 2025 Guidance … Full-year 2025 Revenue guidance of $15,725 million to $16,125 million, Adjusted EBITDA of $3,765 million to $3,885 million and Adjusted Diluted Earnings per Share of $11.70 to $12.10 release 2025-02-06
Full-Year 2025 Guidance … The company reaffirms its profit guidance of Adjusted EBITDA between $3,765 million and $3,885 million, and Adjusted Diluted Earnings per Share between $11.70 and $12.10. release 2025-05-06
Full-Year 2025 Guidance … The company is updating its full-year 2025 guidance as follows: revenue between $16,100 million and $16,300 million, Adjusted EBITDA between $3,750 million and $3,825 million, and Adjusted Diluted Earnings per Share between $11.75 and $12.05. release 2025-07-22
Full-Year 2025 Guidance … The company is reaffirming the midpoint of its full-year 2025 guidance and narrowing the ranges as follows: revenue expected to be between $16,150 million and $16,250 million, Adjusted EBITDA expected to be between $3,775 million and $3,800 million, and Adjusted Diluted Earnings per Share expected to be between $11.85 and $11.95. release 2025-10-28
Revenue
Fiscal 2025 (ended 2025-12-31)
Given $15.72B to $16.12B release 2025-02-06
Raised $16.00B to $16.40B release 2025-05-06
Narrowed $16.10B to $16.30B release 2025-07-22
Narrowed $16.15B to $16.25B release 2025-10-28
$16.31B
10-K filed 2026-02-17
Above the range
The company's words
Full-year 2025 Revenue guidance of $15,725 million to $16,125 million, Adjusted EBITDA of $3,765 million to $3,885 million and Adjusted Diluted Earnings per Share of $11.70 to $12.10 release 2025-02-06
To reflect the favorable change in foreign currency exchange rates since the company released its prior guidance, the company is raising its full-year 2025 revenue guidance to be between $16,000 million and $16,400 million. release 2025-05-06
The company is updating its full-year 2025 guidance as follows: revenue between $16,100 million and $16,300 million, Adjusted EBITDA between $3,750 million and $3,825 million, and Adjusted Diluted Earnings per Share between $11.75 and $12.05. release 2025-07-22
The company is reaffirming the midpoint of its full-year 2025 guidance and narrowing the ranges as follows: revenue expected to be between $16,150 million and $16,250 million, Adjusted EBITDA expected to be between $3,775 million and $3,800 million, and Adjusted Diluted Earnings per Share expected to be between $11.85 and $11.95. release 2025-10-28
EBITDA (company-defined)
Fiscal 2024 (ended 2024-12-31)
Given $3.70B to $3.80B release 2024-05-02
Lowered $3.71B to $3.77B release 2024-07-22
Lowered $3.67B to $3.70B release 2024-10-31
– No standard number
The company's words
Full-Year 2024 Guidance … The company reaffirms its full-year Adjusted EBITDA guidance of $3,700 million to $3,800 million, representing growth of 3.7 to 6.5 percent. release 2024-05-02
Full-year 2024 guidance updated for revenue to be between $15,425 million and $15,525 million, Adjusted EBITDA between $3,705 million and $3,765 million, and Adjusted Diluted Earnings per Share between $11.10 and $11.30 release 2024-07-22
Full-year 2024 guidance updated for revenue to be between $15,350 million and $15,400 million, Adjusted EBITDA between $3,675 million and $3,700 million, and Adjusted Diluted Earnings per Share between $11.10 and $11.20 release 2024-10-31
Diluted EPS (company-defined)
Fiscal 2024 (ended 2024-12-31)
Given $10.95 to $11.25 release 2024-05-02
Raised $11.10 to $11.30 release 2024-07-22
Lowered $11.10 to $11.20 release 2024-10-31
– No standard number
The company's words
Full-Year 2024 Guidance … The company reaffirms its full-year Adjusted Diluted EPS guidance of $10.95 to $11.25, up 7.4 to 10.3 percent year-over-year. release 2024-05-02
Full-year 2024 guidance updated for revenue to be between $15,425 million and $15,525 million, Adjusted EBITDA between $3,705 million and $3,765 million, and Adjusted Diluted Earnings per Share between $11.10 and $11.30 release 2024-07-22
Full-year 2024 guidance updated for revenue to be between $15,350 million and $15,400 million, Adjusted EBITDA between $3,675 million and $3,700 million, and Adjusted Diluted Earnings per Share between $11.10 and $11.20 release 2024-10-31
Revenue
Fiscal 2024 (ended 2024-12-31)
Given $15.40B to $15.65B release 2024-02-14
Lowered $15.43B to $15.53B release 2024-07-22
Lowered $15.35B to $15.40B release 2024-10-31
$15.40B
10-K filed 2025-02-13
Above the range
The company's words
Full-Year 2024 GuidanceFor the full year of 2024, the company expects revenue to be between $15,400 million and $15,650 million. release 2024-02-14
Full-year 2024 guidance updated for revenue to be between $15,425 million and $15,525 million, Adjusted EBITDA between $3,705 million and $3,765 million, and Adjusted Diluted Earnings per Share between $11.10 and $11.30 release 2024-07-22
Full-year 2024 guidance updated for revenue to be between $15,350 million and $15,400 million, Adjusted EBITDA between $3,675 million and $3,700 million, and Adjusted Diluted Earnings per Share between $11.10 and $11.20 release 2024-10-31

Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (13 releases since 2023-11-01), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.

Next Archive →